A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014)

Clinical trial NCT06052566 · COMPLETED

Trial details

NCT number: NCT06052566
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-alcoholic Steatohepatitis Hepatic Impairment

Start date: 2023-11-21
Primary completion: 2024-12-05
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.